The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection

Transplantation

Volumn 62, Issue 12, 1996, Pages 1912-1915

  Selvaggi, Gennaro ^a   Ricordi, Camillo ^a   Podack, Eckhard R ^a   Inverardi, Luca ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL MEDIATED CYTOTOXICITY; CONFERENCE PAPER; CYTOTOXICITY; GRAFT REJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SKIN TRANSPLANTATION;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PORE FORMING CYTOTOXIC PROTEINS; RATS; RATS, INBRED LEW; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030458560     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612270-00040     Document Type: Conference Paper

References (21)

1. Steinmuller D. Which T cells mediate allograft rejection? Transplantation 1985; 40: 229.
2. Mason DW, Morris PJ. Effector mechanisms in allograft rejection. Annu Rev Immunol 1986; 4: 119.
3. Golding H, Singer A. Specificity, phenotype and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens. J Immunol 1985; 135: 1610.
4. Golding H, Mizuoki T, McCarthy SA, Cleveland C, Singer A. Relationship among function, phenotype and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. J Immunol 1987; 138: 10.
5. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994; 369: 31.
6. ++-indipendent T-cell mediated cytotoxicity. J Exp Med 1988; 177: 195.
7. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183: 657.
8. Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis? Annu Rev Immunol 1991; 9: 129.
9. Billingham RE. In: Billingham RE, Silvers WR, eds. Transplantation of tissues and cells. Philadelphia: Wistar Institute, 1961: 1.
10. b mutant skin allografts differing at class I MHC. Nature 1986; 322: 829.
11. Kobayashi E, Fujiwara M. Mechanisms of rejection of MHC class II-disparate murine grafts. I. Immunohistochemical analysis of T-cell subsets infiltrating the site of the graft. Transplant Proc 1992; 24: 419.
12. Clement MV, Legros-Maida S, Israel-Biet D, et al. Perforin and granzyme B expression is associated with severe acute rejection. Transplantation 1994; 57: 322.
13. Mueller C, Shao Y, Altermatt HJ, Hess MW, Shelby J. The effect of cyclosporine treatment on the expression of genes encoding granzyme A and perforin in the infiltrate of mouse heart transplants. Transplantation 1993; 55: 139.
14. Shulz M, Schuurman HJ, Joergesen J, et al. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 1995; 25: 474.
15. Lu X, Ledermann B, Borel JF. Survival of islet grafts in perforin-deficient mice. Transplant Proc 1995; 27: 3262.
16. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
17. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 in preventing graft rejection. Nature 1995; 377: 630.
18. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.
19. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity: an immunoeffector or immunoregulatory pathway in T cell-mediated immune response. Transplantation 1995; 60: 221.
20. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16: 39.
21. Vossen ACTM, Tibbe GJM, Benner R, Savelkoul HFJ. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice. Transplant Proc 1995; 27: 380.